Detalhe da pesquisa
1.
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.
Nat Immunol
; 24(11): 1867-1878, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798557
2.
SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer.
Gut
; 72(4): 722-735, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882214
3.
Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
J Pathol
; 258(4): 408-425, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102377
4.
Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α.
Genes Dev
; 28(23): 2621-35, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25452273
5.
Phosphorylation of the MNK1 substrate eIF4E is not required for response to acute pancreatitis.
Pancreatology
; 21(4): 677-681, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648878
6.
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
Pharmacol Rev
; 70(4): 763-835, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232095
7.
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
J Pathol
; 248(1): 51-65, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575030
8.
Stromal protein ßig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
Gut
; 68(4): 693-707, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415234
9.
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.
Int J Mol Sci
; 20(19)2019 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31547627
10.
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Gastroenterology
; 148(7): 1452-65, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683115
11.
4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation.
EMBO J
; 28(22): 3514-22, 2009 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19834456
12.
Pancreatic cancer orthotopic graft in a murine model.
Acta Cir Bras
; 38: e382823, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556720
13.
Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).
bioRxiv
; 2023 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37745612
14.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Br J Pharmacol
; 180 Suppl 2: S23-S144, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123151
15.
Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.
Proc Natl Acad Sci U S A
; 106(42): 17769-74, 2009 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19805200
16.
Changes in translational control after pro-apoptotic stress.
Int J Mol Sci
; 14(1): 177-90, 2012 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344027
17.
Translational alterations in pancreatic cancer: a central role for the integrated stress response.
NAR Cancer
; 4(4): zcac031, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325577
18.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077801
19.
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Cancers (Basel)
; 14(24)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551754
20.
Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
Gastroenterology
; 138(4): 1595-606, 1606.e1-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20080097